Injectable Alzheimer’s Drugs Could Save Patients Trips to the Hospital

The recent approvals of Leqembi (lecanemab) and Kisunla (donanemab) have refreshed the landscape of Alzheimer’s disease treatments. For the first time, patients have the option to take a drug that could slow the progression of the fatal disease and afford them more valuable time and cognitive…

Injectable Alzheimer’s Drugs Could Save Patients Trips to the Hospital …C0NTINUE READING >>>>

Leave a Comment